- Home
- KOF vs WGSWW Comparison
KOF vs WGSWW Comparison
Compare KOF & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOF
- WGSWW
- Stock Information
- Founded
- KOF 1979
- WGSWW 2017
- Country
- KOF Mexico
- WGSWW United States
- Employees
- KOF N/A
- WGSWW N/A
- Industry
- KOF Beverages (Production/Distribution)
- WGSWW Retail: Computer Software & Peripheral Equipment
- Sector
- KOF Consumer Staples
- WGSWW Technology
- Exchange
- KOF Nasdaq
- WGSWW Nasdaq
- Market Cap
- KOF N/A
- WGSWW N/A
- IPO Year
- KOF 1993
- WGSWW N/A
- Fundamental
- Price
- KOF $92.33
- WGSWW $0.16
- Analyst Decision
- KOF Strong Buy
- WGSWW
- Analyst Count
- KOF 5
- WGSWW 0
- Target Price
- KOF $104.00
- WGSWW N/A
- AVG Volume (30 Days)
- KOF 169.8K
- WGSWW 37.1K
- Earning Date
- KOF 04-23-2025
- WGSWW 02-18-2025
- Dividend Yield
- KOF 3.49%
- WGSWW N/A
- EPS Growth
- KOF 21.45
- WGSWW N/A
- EPS
- KOF 5.42
- WGSWW N/A
- Revenue
- KOF $13,427,442,899.00
- WGSWW $305,450,000.00
- Revenue This Year
- KOF $9.28
- WGSWW N/A
- Revenue Next Year
- KOF $6.52
- WGSWW N/A
- P/E Ratio
- KOF $17.03
- WGSWW N/A
- Revenue Growth
- KOF 14.16
- WGSWW 50.79
- 52 Week Low
- KOF $72.68
- WGSWW $0.16
- 52 Week High
- KOF $102.28
- WGSWW $0.24
- Technical
- Relative Strength Index (RSI)
- KOF 65.28
- WGSWW N/A
- Support Level
- KOF $87.58
- WGSWW N/A
- Resistance Level
- KOF $92.57
- WGSWW N/A
- Average True Range (ATR)
- KOF 1.77
- WGSWW 0.00
- MACD
- KOF 0.10
- WGSWW 0.00
- Stochastic Oscillator
- KOF 89.36
- WGSWW 0.00
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.